These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12514953)

  • 21. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis.
    Serrano-Martín X; Payares G; Mendoza-León A
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4214-6. PubMed ID: 17015627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Santos CC; Zhang H; Batista MM; de Oliveira GM; Demarque KC; da Silva-Gomes NL; Moreira OC; Ogungbe IV; Soeiro MNC
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32928731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activities of thiadiazine derivatives against Leishmania amazonensis.
    Monzote L; Montalvo AM; Fonseca L; Pérez R; Suárez M; Rodríguez H
    Arzneimittelforschung; 2005; 55(4):232-8. PubMed ID: 15901047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of the local or oral delivery of the novel naphthopterocarpanquinone LQB-118 against cutaneous leishmaniasis.
    da Cunha-Júnior EF; Pacienza-Lima W; Ribeiro GA; Netto CD; do Canto-Cavalheiro MM; da Silva AJ; Costa PR; Rossi-Bergmann B; Torres-Santos EC
    J Antimicrob Chemother; 2011 Jul; 66(7):1555-9. PubMed ID: 21531758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical Characterization, Antileishmanial Activity, and Cytotoxicity Effects of the Essential Oil from Leaves of Pluchea carolinensis (Jacq.) G. Don. (Asteraceae).
    García M; Scull R; Satyal P; Setzer WN; Monzote L
    Phytother Res; 2017 Sep; 31(9):1419-1426. PubMed ID: 28703380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis.
    García Bustos MF; Barrio A; Prieto GG; de Raspi EM; Cimino RO; Cardozo RM; Parada LA; Yeo M; Soto J; Uncos DA; Parodi C; Basombrío MA
    J Parasitol; 2014 Dec; 100(6):840-7. PubMed ID: 25014108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo activity of perifosine against Leishmania amazonensis.
    Cabrera-Serra MG; Valladares B; Piñero JE
    Acta Trop; 2008 Oct; 108(1):20-5. PubMed ID: 18801328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis.
    da Silva ET; de Andrade GF; Araújo ADS; Almeida ADC; Coimbra ES; de Souza MVN
    Acta Parasitol; 2020 Mar; 65(1):203-207. PubMed ID: 31832921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of hydroxyurea against Leishmania mexicana.
    Martinez-Rojano H; Mancilla-Ramirez J; Quiñonez-Diaz L; Galindo-Sevilla N
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3642-7. PubMed ID: 18694950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leishmanicidal Activity of Isoselenocyanate Derivatives.
    Fernández-Rubio C; Larrea E; Peña Guerrero J; Sesma Herrero E; Gamboa I; Berrio C; Plano D; Amin S; Sharma AK; Nguewa PA
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronate.
    Rodriguez N; Bailey BN; Martin MB; Oldfield E; Urbina JA; Docampo R
    J Infect Dis; 2002 Jul; 186(1):138-40. PubMed ID: 12089677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.
    Souza-Silva F; Bourguignon SC; Pereira BA; Côrtes LM; de Oliveira LF; Henriques-Pons A; Finkelstein LC; Ferreira VF; Carneiro PF; de Pinho RT; Caffarena ER; Alves CR
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1910-8. PubMed ID: 25583728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A natural cell-penetrating nanopeptide combined with pentavalent antimonial as experimental therapy against cutaneous leishmaniasis.
    Valentim Silva JR; de Barros NB; Aragão Macedo SR; Ferreira ADS; Moreira Dill LS; Zanchi FB; do Nascimento JR; Fernandes do Nascimento FR; Lourenzoni MR; de Azevedo Calderon L; Soares AM; Nicolete R
    Exp Parasitol; 2020 Oct; 217():107934. PubMed ID: 32698075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity.
    Grant KM; Dunion MH; Yardley V; Skaltsounis AL; Marko D; Eisenbrand G; Croft SL; Meijer L; Mottram JC
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3033-42. PubMed ID: 15273118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.
    Miguel DC; Yokoyama-Yasunaka JK; Andreoli WK; Mortara RA; Uliana SR
    J Antimicrob Chemother; 2007 Sep; 60(3):526-34. PubMed ID: 17584801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antileishmanial activity of quinazoline derivatives: synthesis, docking screens, molecular dynamic simulations and electrochemical studies.
    Mendoza-Martínez C; Galindo-Sevilla N; Correa-Basurto J; Ugalde-Saldivar VM; Rodríguez-Delgado RG; Hernández-Pineda J; Padierna-Mota C; Flores-Alamo M; Hernández-Luis F
    Eur J Med Chem; 2015 Mar; 92():314-31. PubMed ID: 25576738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana.
    Aguilar Torrentera F; Lambot MA; Laman JD; Van Meurs M; Kiss R; Noël JC; Carlier Y
    Am J Trop Med Hyg; 2002 Mar; 66(3):273-9. PubMed ID: 12139220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.